Skip to Main Content
Diabetes Mellitus - Type 2 | Obesity & Weight Control, Phase III

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once-Weekly Eloralintide versus Placebo in Adult Participants with Obesity who are on stable incretin background.

Contact Information

For more information about this study, including how to volunteer, contact Y-Weight Obesity Research Center

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    07/12/2026
  • Study IRB
    #2000041604